Gilead Sciences Inc (GILD)
92.57
+1.48
(+1.62%)
USD |
NASDAQ |
Dec 20, 16:00
92.57
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Profit Margin (Quarterly): 16.61% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Eli Lilly and Co | 8.48% |
| Merck & Co Inc | 18.95% |
| AbbVie Inc | 10.80% |
| Amgen Inc | 33.28% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.64% |
| Return on Assets | 0.22% |
| Return on Invested Capital | 0.29% |
| Gross Profit Margin (Quarterly) | 79.14% |
| Operating Margin (Quarterly) | 41.66% |
| Return on Net Operating Assets | 0.28% |